Patients with previous periorbital/forehead surgery
Patients who plucked the upper eyebrow margin
Patients with eyebrow tatoos
Patients with upper face botulinum toxin injection in the past 12 months
Patients with resorbable upper face fillers injection in the past 12 months
Patients with previous permanent upper face fillers injection
Pregnant patients
Lactating patients
Patients with preexisting neuromuscular conditions (myasthenia gravis, Eaton Lambert syndrome)
Patients using medication that could potentiate the effect of botulinum (ex: aminoglycoside antibiotics)
Patients with sensitivity to botulinum toxin or human albumin

NCT02942303_exc_T1
Procedure
forehead surgery
NCT02942303_exc_T2
Procedure
periorbital surgery
NCT02942303_exc_T3
Condition
plucked the upper eyebrow margin
NCT02942303_exc_T4
Observation
eyebrow tatoos
NCT02942303_exc_T5
Procedure
botulinum toxin injection
NCT02942303_exc_T6
Qualifier
upper face
NCT02942303_exc_T7
Temporal
in the past 12 months
NCT02942303_exc_T8
Temporal
in the past 12 months
NCT02942303_exc_T9
Procedure
rbable upp ers injection in
NCT02942303_exc_T10
Qualifier
upper face
NCT02942303_exc_T11
Procedure
nent uppe rs injection
Preg
NCT02942303_exc_T12
Qualifier
upper face
NCT02942303_exc_T13
Condition
Pregnant
NCT02942303_exc_T14
Condition
Lactating
NCT02942303_exc_T15
Condition
neuromuscular conditions
NCT02942303_exc_T16
Condition
myasthenia gravis
NCT02942303_exc_T17
Condition
Eaton Lambert syndrome
NCT02942303_exc_T18
Scope
myasthenia gravis, Eaton Lambert syndrome
NCT02942303_exc_T19
Drug
botulinum
NCT02942303_exc_T20
Condition
potentiate the effect
NCT02942303_exc_T21
Drug
medication
NCT02942303_exc_T22
Drug
aminoglycoside antibiotics
NCT02942303_exc_T23
Scope
medication that could potentiate the effect of botulinum
NCT02942303_exc_T24
Drug
botulinum toxin
NCT02942303_exc_T25
Drug
human albumin
NCT02942303_exc_T26
Condition
sensitivity
NCT02942303_exc_T27
Scope
botulinum toxin or human albumin